Biological mediators for periodontal regeneration

Periodontology 2000

Volumn 19, Issue 1, 1999, Pages 40-58

  Cochran, David L ^a   Wozney, John M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; ENAMEL PROTEIN; GROWTH PROMOTOR; PROSTAGLANDIN; SCLEROPROTEIN;

ANIMAL; BONE REGENERATION; HUMAN; METABOLISM; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTIUM; PHYSIOLOGY; REGENERATION; REVIEW;

ALVEOLAR BONE LOSS; ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DENTAL ENAMEL PROTEINS; EXTRACELLULAR MATRIX PROTEINS; GROWTH SUBSTANCES; HUMANS; PERIODONTAL DISEASES; PERIODONTIUM; PROSTAGLANDINS; REGENERATION;

EID: 0033069584     PISSN: 09066713     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0757.1999.tb00146.x     Document Type: Article

References (109)

1. Alger FA, Solt CW, Vuddhakanok S, Miles K. The histologic evaluation of new attachment in periodontally diseased human roots treated with tetracycline-hydrochloride and fibronectin. J Periodontol 1990: 61: 447-455.
2. Aspenberg P, Thorngren KG, Lohmander LS. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats. Acta Orthop Scand 1991: 62: 481-484.
3. Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 1993: 8(suppl 2): S565-S572.
4. Beck LS, Ammann AJ, Aufdemorte TB, Deguzman L, Xu Y, Lee WP, McFatridge LA, Chen TL. In vivo induction of bone by recombinant human transforming growth factor β1. J Bone Miner Res 1991: 6: 961-968.
5. Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Gillett NA, Amento EP. TGF-β1 induces bone closure of skull defects. J Bone Miner Res 1991: 6: 1257-1264.
6. Becker W, Lynch SE, Lekholm U, Becker BE, Caffesse R, Donath K, Sanchez R. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-I or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. J Periodontol 1992: 63: 929-940.
7. Boden SD, Hair G, Titus L, Racine M, McCuaig K, Wozney JM, Nanes MS. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 1997: 138: 2820-2828.
8. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM, Nanes MS. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 1996: 137: 3401-3407.
9. Bonewald LF, Mundy GR. Role of transforming growth factor-β in bone remodeling. Clin Orthop 1990: 250: 261-276.
10. Bowers G, Felton F, Middleton C, Glynn D, Sharp S, Mellonig J, Corio R, Emerson J, Park S, Suzuki J, Ma S, Romberg E, Reddi AH. Histologic comparison of regeneration in human intrabony defects when osteogenin is combined with demineralized freeze-dried bone allograft and with purified bovine collagen. J Periodontol 1991: 62: 690-702.
11. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997: 17: 10-25.
12. Caffesse RG, Holden MJ, Kon S, Nasjleti CE. The effect of citric acid and fibronectin application on healing following surgical treatment of naturally occurring periodontal disease in beagle dogs. J Clin Periodontol 1985: 12: 578-590.
13. Caffesse RG, Kerry GJ, Chaves ES, McLean TN, Morrison EC, Lopatin DE, Caffesse ER, Stults DL. Clinical evaluation of the use of citric acid and autologous fibronectin in periodontal surgery. J Periodontol 1988: 59: 565-569.
14. Caffesse RG, Quiñones CR. Polypeptide growth factors and attachment proteins in periodontal wound healing and regeneration. Periodontol 2000 1993: 1: 69-79.
15. Canalis E. Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae. Calcif Tissue Int 1984: 36: 158-166.
16. Canalis E, McCarthy TL, Centrella M. Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol 1989: 140: 530-537.
17. Canalis E, Pash J, Gabbitas B, Rydziel S, Varghese S. Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. Endocrinology 1993: 133: 33-38.
18. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990: 87: 9843-9847.
19. Centrella M, McCarthy TL, Canalis E. Transforming growth factor-β and remodeling of bone. J Bone Joint Surg Am 1991: 73A: 1418-1428.
20. Centrella M, McCarthy TL, Kusmik WF, Canalis E. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures from fetal rat bone. J Cell Physiol 1991: 147: 420-426.
21. Centrella M, Rosen V, Wozney JM, Casinghino SR, McCarthy TL. Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J Cell Biochem 1997: 67: 528-540.
22. Cho MI, Lin WL, Genco RJ. Platelet-derived growth factor-modulated guided tissue regenerative therapy. J Periodontol 1995: 66: 522-530.
23. Cochran DL, Nummikoski PV, Jones AA, Makins SR, Turek TJ, Buser D. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 1997: 12: 739-748.
24. Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol (in press).
25. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989: 10: 68-91.
26. Desimone DP, Greene VS, Hannon KS, Turner RT, Bell NH. Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease. J Bone Miner Res 1993: 8: 625-634.
27. Gestrelius S, Andersson C, Johansson AC, Persson E, Brodin A, Rydhag L, Hammarström L. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 1997: 24: 678-884.
28. Gestrelius S, Andersson C, Lidström D, Hammarström L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997: 24: 685-692.
29. Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J Periodontol 1994: 65: 1158-1168.
30. Giannobile WV, Hernandez RA, Finkelman RD, Ryan S, Kiritsy CP, D'Andrea M, Lynch SE. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodont Res 1996: 31: 301-312.
31. Graves DT, Cochran DL. Mesenchymal cell growth factors. Crit Rev Oral Biol Med 1990: 1: 17-36.
32. Graves DT, Cochran DL. Biologically active mediators: platelet-derived growth factor, monocyte chemoattractant protein-1, and transforming growth factor-β. Curr Opin Dent 1991: 1: 809-815.
33. Graves DT, Cochran DL. Periodontal regeneration with polypeptide growth factors. Curr Opin Periodontol 1994: 178-186.
34. Graves DT, Kang YM, Kose KN. Growth factors in periodontal regeneration. Compendium Contin Educ Dent 1994: suppl 18: S672-S677.
35. Graves DT, Valentin-Opran A, Delgado R, Valente AJ, Mundy G, Piche J. The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells. Connect Tissue Res 1989: 23: 209-218.
36. Gronowicz GA, McCarthy MB. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels. Endocrinology 1995: 136: 598-808.
37. Hammacher A, Hellman U, Johnsson A, Ostman A, Gunnarsson K, Westermark B, Wasteson A, Heldin CH. A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem 1988: 263: 16493-16498.
38. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997: 24: 658-868.
39. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997: 24: 669-677.
40. Hanisch O, Cortella CA, Boskovic MM, James RA, Slots J, Wikesjö UME. Experimental peri-implant tissue breakdown around hydroxyapatite-coated implants. J Periodontol 1997: 68: 59-66.
41. Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UME. Bone formation and reosseointegration in periimplantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 1997: 12: 604-610.
42. Hanisch O, Tatakis DN, Rohrer MD, Wöhrle PS, Wozney JM, Wikesjö UME. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 1997: 12: 785-792.
43. Heijl L, Heden G, Svärdström G, Östgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997: 24: 705-714.
44. Hogan BLM. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996: 10: 1580-1594.
45. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997: 17: 124-139.
46. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997: 68: 1186-1193.
47. Hughes FJ. Chemotactic effects of BMP2 on osteoblastic and fibroblastic cell lines. J Dent Res 1992: 71: 730.
48. Hurley MM, Florkiewicz RZ. Fibroblast growth factor and vascular endothelial cell growth factor families. In: Bilezikian JP, Raisz LG, Rodan GA, ed. Principles of bone biology. San Diego: Academic Press, 1996: 627-445.
49. Ishikawa I, Kinoshita A, Oda S, Roongruanphol T. Regenerative therapy in periodontal diseases. Histological observations after implantation of rhBMP-2 in the surgically created periodontal defects in dogs. Dent Jpn 1994: 31: 141-146.
50. Jin Y, Wang X, Liu B, White FH. Early histologic response to titanium implants complexed with bovine bone morphogenetic protein. J Prosthet Dent 1994: 71: 289-294.
51. Jingushi S, Heydemann A, Kana SK, Macey LR, Bolander ME. Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. J Orthop Res 1990: 8: 364-371.
52. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990: 110: 2195-2207.
53. Kawaguchi H, Pilbeam CC, Vargas SJ, Morse EE, Lorenzo JA, Raisz LG. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 1995: 96: 539-548.
54. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995: 136: 3054-3061.
55. King GN, King N, Cruchley AT, Wozney JM, Hughes FJ. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 1997: 76: 1460-1470.
56. Kinoshita A, Oda S, Takahashi K, Yokota S, Ishikawa I. Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs. J Periodontol 1997: 68: 103-109.
57. Lee MB. Bone morphogenetic proteins: background and implications for oral reconstruction - a review. J Clin Periodontol 1997: 24: 355-365.
58. Lind M, Eriksen EF, Bunger C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 1996: 18: 53-57.
59. Lukert BP, Kream BE. Clinical and basic aspects of glucocorticoid action in bone. In: Bilezikian JP, Raisz LG, Rodan GA, ed. Principles of bone biology. San Diego: Academic Press, 1996: 533-548.
60. Lynch SE, Buser D, Hernandez RA, Weber HP, Stich H, Fox CH, Williams RC. Effects of the platelet-derived growth factor/insulin-like growth factor-1 combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol 1991: 62: 710-716.
61. Lynch SE, Ruiz de Castilla G, Williams RC, Kiritsy CP, Howell TH, Reddy MS, Antoniades HN. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991: 62: 458-467.
62. Lynch SE, Williams RC, Polson AM, Howell TH, Reddy MS, Zappa UE, Antoniades HN. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 1989: 16: 545-548.
63. Marks SC Jr, Miller S. Local infusion of prostaglandin E1 stimulates mandibular bone formation in vivo. J Oral Pathol 1988: 17: 500-505.
64. Marks SC Jr, Miller SC. Local delivery of prostaglandin E1 induces periodontal regeneration in adult dogs. J Periodont Res 1994: 29: 103-108.
65. Massagu JJ. Type beta transforming growth factor from feline sarcoma virus-transformed rat cells. Isolation and biological properties. J Biol Chem 1984: 259: 9756-9761.
66. Miller SC, Marks SC Jr. Alveolar bone augmentation following the local administration of prostaglandin E1 by controlled-release pellets. Bone 1993: 14: 587-593.
67. 1: quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets. Bone 1993: 14: 143-151.
68. Nevins M, Kirker-Head C, Wozney JM, Palmer R, Graham D. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. Int J Periodontics Restorative Dent 1996: 16: 9-19.
69. Noda M, Camilliere JJ. In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 1989: 124: 2991-2994.
70. Oates TW, Rouse CA, Cochran DL. Mitogenic effects of growth factors on human periodontal ligament cells in vitro. J Periodontol 1993: 64: 142-148.
71. Özkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J 1990: 9: 2085-2093.
72. Park JB, Matsuura M, Han KY, Norderyd O, Lin WL, Genco RJ, Cho MI. Periodontal regeneration in class III furcation defects of beagle dogs using guided tissue regenerative therapy with platelet-derived growth factor. J Periodontol 1995: 66: 462-477.
73. Pilbeam CC, Harrison JR, Raisz LG. Prostaglandins and bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, 1996: 715-728.
74. Reddi AH. Cell biology and biochemistry of endochondral bone development. Collagen Rel Res 1981: 1: 209-226.
75. Ripamonti U, Bosch C, van den Heever B, Duneas N, Melsen B, Ebner R. Limited chondro-osteogenesis by recombinant human transforming growth factor-beta(1) in calvarial defects of adult baboons (Papio ursinus). J Bone Miner Res 1996: 11: 938-945.
76. Ripamonti U, Heliotis M, Rueger DC, Sampath TK. Induction of cementogenesis by recombinant human osteogenic protein-1 (hOP-1/BMP-7) in the baboon (Papio ursinus). Arch Oral Biol 1996: 41: 121-126.
77. Ripamonti U, Heliotis M, van den Heever B, Reddi AH. Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus). J Periodontal Res 1994: 29: 439-445.
78. Ripamonti U, Reddi AH. Periodontal regeneration: potential role of bone morphogenetic proteins. J Periodont Res 1994: 29: 225-235.
79. Rosen V, Cox K, Hattersley G. Bone morphogenetic proteins. In: Bilezikian JP, Raisz LG, Rodan GA, ed. Principles of bone biology. San Diego: Academic Press, 1996: 661-671.
80. Rutherford RB, Niekrash CE, Kennedy JE, Charette MF. Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J Periodont Res 1992: 27: 285-290.
81. Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, Charette MF. Platelet-derived growth factor and dexamethasone combined with a collagen matrix induce regeneration of the periodontium in monkeys. J Clin Periodontol 1993: 20: 537-544.
82. Rutherford RB, Sampath TK, Rueger DC, Taylor TD. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants 1992: 7: 297-301.
83. Selvig KA, Wikesjö UME, Bogle GC, Finkelman RD. Impaired early bone formation in periodontal fenestration defects in dogs following application of insulin-like growth factor. II. Basic fibroblast growth factor and transforming growth factor β1. J Clin Periodontol 1994: 21: 380-385.
84. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1991: 3: 243-266.
85. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UME. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997: 8: 367-374.
86. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjö UME. Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995: 66: 131-138.
87. Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM, Wikesjö UME. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996: 16: 525-537.
88. Slavkin HC. Towards a cellular and molecular understanding of periodontics. Cementogenesis revisited. J Periodontol 1976: 47: 249-255.
89. Smith BA, Smith JS, Caffesse RG, Nasjleti CE, Lopatin DE, Kowalski CJ. Effect of citric acid and various concentrations of fibronectin on healing following periodontal flap surgery in dogs. J Periodontol 1987: 58: 667-473.
90. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: biological function and chemical structure. Science 1986: 233: 532-534.
91. Terranova VP, Martin GR. Molecular factors determining gingival tissue interaction with tooth structure. J Periodont Res 1982: 17: 530-533.
92. Terranova VP, Odziemiec C, Tweden KS, Spadone DP. Repopulation of dentin surfaces by periodontal ligament cells and endothelial cells. Effect of basic fibroblast growth factor. J Periodontol 1989: 60: 293-301.
93. Terranova VP, Wikesjö UME. Chemotaxis of cells isolated from periodontal tissues to different biological response modifiers. Adv Dent Res 1988: 2: 215-222.
94. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Arch Otolaryngol Head Neck Surg 1991: 117: 1101-1112.
95. Tweden KS, Spadone DP, Terranova VP. Neovascularization of surface demineralized dentin. J Periodontol 1989: 60: 460-466.
96. Urist MR. Bone: formation by autoinduction. Science 1965: 150: 893-899.
97. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, Wozney JM. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A 1988: 85: 9484-9488.
98. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel D, Hewick RM, Kerns K, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos I, Nove J, Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990: 87: 2220-2224.
99. Wang HL, Pappert TD, Castelli WA, Chiego DJ Jr, Shyr Y, Smith BA. The effect of platelet-derived growth factor on the cellular response of the periodontium: an autoradiographic study on dogs. J Periodontol 1994: 65: 429-436.
100. Wang X, Jin Y, Liu B, Zhou S, Yang L, Xi Y, White FH. Tissue reactions to titanium implants containing bovine bone morphogenetic protein: a scanning electron microscopic investigation. Int J Oral Maxillofac Surg 1994: 23: 115-119.
101. Wang X, Liu B, Jin Y, Xi Y. The effect of bone morphogenetic protein on osseointegration of titanium implants. J Oral Maxillofac Surg 1993: 51: 647-451.
102. Westermark B, Heldin CH. Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth. Acta Oncol 1993: 32: 101-105.
103. Wikesjö UME, Claffey N, Christersson LA, Franzetti LC, Genco RJ, Terranova VP, Egelberg J. Repair of periodontal furcation defects in beagle dogs following reconstructive surgery including root surface demineralization with tetracycline hydrochloride and topical fibronectin application. J Clin Periodontol 1988: 15: 73-80.
104. Wikesjö UME, Razi SS, Sigurdsson TJ, Tatakis DN, Lee MB, Ongpipattanakul B, Nguyen T, Hardwick R. Periodontal repair in dogs: effect of recombinant human transforming growth factor-β1 on guided tissue regeneration. J Clin Periodontol 1998: 25: 475-481.
105. Wozney JM. Bone morphogenetic proteins and their gene expression. In: Noda M, ed. Cellular and molecular biology of bone. San Diego: Academic Press, 1993: 131-167.
106. Wozney JM. The potential role of bone morphogenetic proteins in periodontal reconstruction. J Periodontol 1995: 66: 506-510.
107. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988: 242: 1528-1534.
108. Yang RS, Liu TK, Lin-Shiau SY. Increased bone growth by local prostaglandin E2 in rats. Calcif Tissue Int 1993: 52: 57-41.
109. Zetterström O, Andersson C, Eriksson L, Fredriksson A, Friskopp J, Heden G, Jansson B, Lundgren T, Nilvéus R, Olsson A, Renvert S, Salonen L, Sjöström L, Winell A, Östgren A, Gestrelius S. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 1997: 24: 697-704.